Position in HALO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$425,319
-$37,431 QoQ
Shares Held
5,434
-24.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#411
of 664 holders
Holding Since
Mar 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $3,911,455 across 6 Biotechnology names. HALO ranks #6 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
15,431 | $865,216 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
2,804 | $799,055 | |
| 3 | EXEL |
Exelixis, Inc.
|
12,392 | $674,248 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,344 | $667,605 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,992 | $480,012 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
5,434 | $425,319 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $425,319 | 5,434 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $462,750 | 7,160 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $481,868 | 7,160 | Shares | Sole | 2026-02-12 | |
| 2021-06-30 | $255,385 | 5,624 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $234,464 | 5,624 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||